Dr. Rachmilewitz serves as the Chief Medical Officer at BioLineRx, formerly the Senior Vice President of Clinical Development at VBL Therapeutics. She is a clinical research physician executive with over 15 years of experience in Clinical Development and Medical Affairs roles in the Healthcare Industry previously working at, Teva, Novartis and Neuroderm. Dr. Rachmilewitz holds an M.D. from the Hadassah Medical School at the Hebrew University in Jerusalem.
